Skip to content

Evaluation of effect of pantoxyfylline in burned patients

Evaluation of effect of pantoxyfylline in reduction of systemic inflammatory response in burned patients above 40%

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2017050133737N1
Enrollment
80
Registered
2017-05-16
Start date
2016-03-20
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Burn. Condition 2: Burn. Condition 3: Burn. Condition 4: Burn. Condition 5: Burn. Condition 6: Burn. Burn and corrosion of head and neck Burn and corrosion of shoulder and upper limb, except wrist and hand Burn and corrosion of trunk Burn and corrosion of wrist and hand Burn and corrosion of hip and lower limb, except ankle and foot Burn and corrosion of ankle and foot

Interventions

Intervention 1: In intervention group Tab pantoxyfylline 400 mg every 8 hours for a week. Intervention 2: In control group Placebo with same shape and null substance.
Treatment - Drugs
In intervention group Tab pantoxyfylline 400 mg every 8 hours for a week
In control group Placebo with same shape and null substance

Sponsors

Vice Chancellor for Research, Tabriz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusion criteria : Burn above 40% of body surface; Admission in maximum of an hour. Exclusion criteria : Known comorbidities such as renal and heart faliure and respiratory disorders; Any other type of trauma; Disagree of patient or first degree relatives for participating in study.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Serum levels of IL-1and IL-6. Timepoint: At admission time and days 3,5 and 7. Method of measurement: Measuring serum levels.;Days of admission to ICU. Timepoint: From admission to discharge. Method of measurement: Registered by days and hours.;Death or discharge. Timepoint: From admission to discharge or death. Method of measurement: Registered outcome.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAmir hossein ladan

Tabriz university of medical sciences

Amir.h.ladan@gmail.com+98 416694441

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026